Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT03179540

Non-operative Management for Locally Advanced Rectal Cancer

Led by Mount Sinai Hospital, Canada · Updated on 2024-11-20

90

Participants Needed

1

Research Sites

454 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a 5 year Phase II study to evaluate the safety of non-operative management (NOM) in patients with low rectal cancer (LRC) who achieve a complete clinical response (cCR) following chemoradiotherapy (CRT). The safety of NOM will be evaluated by assessing (i) rate of local re-growth and (ii) rate of macroscopically positive resection margin (R2) when surgery is required due to local re-growth. NOM will be considered safe or as effective as surgery to achieve local control if the rate of local re-growth is equal to or less than 30% and the rate of a macroscopically positive margin is 0%.

CONDITIONS

Official Title

Non-operative Management for Locally Advanced Rectal Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Completed chemoradiotherapy as standard care for Stage II or III low rectal cancer
  • Planned or probable abdominoperineal resection (APR) surgery
  • Achieved complete clinical response 8 to 10 weeks after finishing chemoradiotherapy
  • At least 18 years old
  • Provided written informed consent
Not Eligible

You will not qualify if you...

  • Unable to undergo MRI scans
  • Presence of metastatic disease including extramesorectal and retroperitoneal lymph nodes
  • Pregnant
  • Have inflammatory bowel disease
  • Have more than one primary colorectal cancer
  • Had another malignancy within 5 years before current rectal cancer treatment
  • Not fit for surgery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Sinai Health System

Toronto, Ontario, Canada, M5T 3L9

Actively Recruiting

Loading map...

Research Team

E

Erin Kennedy

CONTACT

S

Selina Schmocker

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here